News

XOMA Royalty's Tender Offer for LAVA Therapeutics Expanded

XOMA Royalty's Tender Offer for LAVA Therapeutics Expanded

XOMA Royalty Expands Tender Offer for LAVA Therapeutics

XOMA Royalty Corporation, a prominent player in the biotechnology industry, has made headlines by extending its tender offer for LAVA Therapeutics N.V. This decision reflects XOMA's commitment to acquiring the outstanding shares of LAVA, which are indicative of vast potential in the biopharmaceutical landscape.

Details of the Tender Offer

The extension of the tender offer allows shareholders of LAVA to accept a specific cash amount, which will be determined as per the Purchase Agreement. Additionally, shareholders will benefit from a non-transferable contingent value right (CVR) for each share, giving them the right to receive 75% of the net proceeds linked to LAVA’s key partnered assets, along with a share of any proceeds that might arise from out-licensing or selling LAVA’s unpartnered programs.

Expiration Date and Procedures for Shareholders

Initially set to expire just after 11:59 PM Eastern Time on October 3, 2025, the tender offer has now been shifted to October 17, 2025. This extension allows LAVA shareholders more time to consider their options without the pressure of a rapidly approaching deadline. Importantly, those who have already tendered their shares need not take any further steps since their previous actions will stand. Support agreements have been signed by many LAVA shareholders endorsing the tendering of their shares.

Conditions for Closing the Offer

The completion of this acquisition hinges on several key conditions. Most notably, XOMA Royalty aims to secure at least 80%—or in some cases, a minimum of 75%—of LAVA's issued and outstanding shares. Additionally, some resolutions must be approved at a shareholders' meeting, and a minimum cash balance is required at closing, along with standard conditions customary in such transactions. Following the conclusion of this offering period, LAVA plans to undergo a corporate restructuring to facilitate XOMA Royalty’s acquisition of the remaining shares.

About XOMA Royalty Corporation

XOMA Royalty plays a unique and pivotal role in the biotechnology sector. Its mission centers on aggregating royalties and aiding biotech firms in their quest to enhance human health. By acquiring potential future economic rights linked to both pre-commercial and commercial therapeutic candidates, XOMA provides sellers with vital non-dilutive funding. This assists companies in advancing their drug candidates or addressing general corporate needs. The expanded portfolio of XOMA Royalty emphasizes its strategic intention to capture the future revenues associated with promising therapeutic developments.

About LAVA Therapeutics N.V.

LAVA Therapeutics is recognized for its innovative approach to developing clinical-stage bispecific gamma delta T cell engagers, a type of therapeutic agent offering new hope against various cancers. Utilizing its proprietary Gammabody platform, LAVA has partnered with notable companies such as Johnson & Johnson and Pfizer, advancing significant programs targeting CD33 and EGFR, respectively. This collaboration not only enhances LAVA's drug pipeline but further emphasizes its commitment to addressing unmet medical needs in oncology.

Future Considerations

The initiative to extend the tender offer and the acquisition strategy reflect not only confidence in LAVA’s potential but also an agile approach to the evolving biotech market. While this acquisition is still pending various approvals, the strategic partnership could yield considerable benefits for XOMA Royalty and its stakeholders. Such a move is indicative of its forward-thinking mentality and dedication to creating sustainable value in the biotechnology landscape.

Frequently Asked Questions

What is the reason for XOMA Royalty's tender offer extension for LAVA Therapeutics?

The extension provides shareholders more time to consider the offer while ensuring that XOMA secures a sufficient number of shares for successful acquisition.

What is the cash amount referenced in the tender offer?

The cash amount will be finalized according to the Purchase Agreement and is intended to incentivize LAVA shareholders to participate.

Are there any actions required from current LAVA shareholders?

No action is needed for shareholders who have already tendered their shares; they are automatically included in the offer.

What are the primary conditions for closing the tender offer?

XOMA Royalty aims to obtain at least 80% of LAVA shares, with various resolutions needing approval at a shareholder meeting.

How does XOMA Royalty support biotechnology firms?

XOMA provides non-dilutive funding to biotech companies through acquiring future economic rights, thereby aiding them in advancing their research and business efforts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JOYY’s Ad Engine Gives Q3 Growth Some Real Teeth Now

Updated Category News Views 107

Three engines are finally pulling the cart at JOYY, and that is a far more interesting sight than another quarter of livestreaming merely holding together. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% sequentially. Those are sturdy numbers, especially for a business that investors have long tended to box in as...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 122

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 153

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 111

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading
Liquidity Services Faces a Brutal Revenue Reality Check

Updated Category News Views 0

A 19.17% opening haircut is the market ringing the fire alarm, not politely clearing its throat. Liquidity Services reported fiscal fourth-quarter revenue of $106.4 million, roughly 10% below the prior-year quarter, and shareholders got hit hard on November 19, 2026. That reaction is ugly, but it is not mysterious. When a company built around moving surplus inventory...

Continue Reading
Nvidia Lawsuit Allegations Put Disclosure Risk in Focus

Updated Category News Views 67

A lawsuit notice can turn a roaring chip story sour in a hurry, and this one deserves a cold, careful read rather than the usual internet stampede. DJS Law Group says it has filed a securities class action against NVIDIA, alleging that the company made materially false and misleading statements during a stated class period running from October 9, 2025 through November 8,...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 61

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 134

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading
Satellite NTN's $3.22B Promise Needs Real Receipts

Updated Category News Views 64

Dead zones over oceans, deserts, and flight paths are finally becoming a serious commercial problem, not merely a neat engineering demo. That is the muscle behind the satellite non-terrestrial network, or NTN, pitch: connect aircraft, vessels, remote assets, and scattered sensors where terrestrial networks simply do not reach. MarketsandMarkets projects this market will...

Continue Reading

Top 5 Most Recently Viewed Articles

Stantec Gears Up for Q2 2025 Results and Insights Call

Updated Category News Views 119

Stantec Prepares for Q2 2025 Financial Results EDMONTON, Alberta — Stantec, recognized globally for its commitment to sustainable design and engineering, is gearing up to release its second quarter 2025 financial results shortly after market closure on a Wednesday in mid-August. The company’s steadfast dedication to enhancing communities through innovation and...

Continue Reading
Hyundai Motor's INITIUM: A Step Towards Hydrogen Mobility

Updated Category News Views 168

Hyundai Motor Explores a Hydrogen Future with INITIUM Concept Hyundai Motor Company recently held an inspiring event named 'Clearly Committed,' demonstrating its dedication to a future powered by hydrogen fuel technology. During this event, the company unveiled its latest hydrogen fuel cell electric vehicle (FCEV) concept, the INITIUM. The Meaning Behind INITIUM The term...

Continue Reading
Target Hospitality Enhances Community Capacity to Meet Demand

Updated Category News Views 130

Target Hospitality Expands Modular Accommodations Target Hospitality Corp. (NASDAQ: TH), a leading provider in the hospitality sector, recently announced a significant expansion of its modular accommodation community. This upgrade represents a 160% increase from their initial offering, aimed at meeting the surging demands of clients in the growing data center industry....

Continue Reading
Nutex Health's Legal Challenge: Misclaimed Bills & Investor Impact

Updated Category News Views 193

Nutex Health Faces Serious Legal Scrutiny Nutex Health Inc. (NASDAQ: NUTX), a company that operates micro-hospitals and healthcare facilities, finds itself in a challenging position as it deals with a class-action lawsuit. This litigation accuses the company of engaging in deceptive billing practices intended to inflate its financial performance. The lawsuit, filed in a...

Continue Reading
Exciting Developments in Uranium Exploration at Foremost Clean Energy

Updated Category News Views 194

Significant Findings at Hatchet Lake Project Foremost Clean Energy Ltd. (NASDAQ: FMST) has announced intriguing results from its latest drilling program at the Hatchet Lake Uranium Property, marking a significant milestone in its exploration efforts. These results stem from their rigorous winter drill program, which underscored the property’s potential for uranium...

Continue Reading